Transfusion therapy resident survival guide: Difference between revisions
Jump to navigation
Jump to search
Line 13: | Line 13: | ||
!Dose | !Dose | ||
|- | |- | ||
|Packed red blood | |Packed [[red blood cell]]s | ||
| | | | ||
| | | | ||
Line 29: | Line 29: | ||
| | | | ||
|- | |- | ||
|Immunoglobulins | |[[Antibody|Immunoglobulins]] | ||
| | | | ||
| | | | ||
Line 41: | Line 41: | ||
| | | | ||
|- | |- | ||
|Cytomegalovirus-negative | |[[Cytomegalovirus]]-negative | ||
| | | | ||
| | | | ||
|- | |- | ||
|Leuko-reduced | |[[Leukoreduction|Leuko-reduced]] | ||
| | | | ||
| | | |
Revision as of 19:40, 12 March 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayokunle Olubaniyi, M.B,B.S [2]
Overview
- Blood transfusion
- Massive blood transfusion
Blood Products and Indications for Use
Blood Products | Indications | Dose |
---|---|---|
Packed red blood cells | ||
Platelets | ||
Fresh frozen plasma | ||
Cryoprecipitate | ||
Immunoglobulins | ||
Albumin | ||
Irradiated | ||
Cytomegalovirus-negative | ||
Leuko-reduced |
Management
General Approach